Principal Investigator
Yelena Drexler
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240853
Clinical Trial Summary
A Double-blinded, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of AION-301 Administered by Intravenous Infusion for the Treatment of Participants with Stage 3 Chronic Kidney Disease
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Danay Saavedra Hernandez
Phone Number
+1 (305) 2436616
Email
dxs4415@miami.edu